LRMR
Larimar Therapeutics Inc
2.80$
-1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.6% | -1.2% | +8.7% | -14.9% | +4.1% | +14.3% | -1.1% | +1.1% | -1.1% | -26.4% | -3.1% | – | |
| – | +5.3% | +10.9% | +8.1% | -15.0% | +23.1% | -23.9% | -0.3% | -2.4% | -12.8% | +27.1% | +8.6% | – | |
| – | – | +15.3% | +165.8% | -231.8% | – | -71.6% | +231.7% | +222.5% | +29.1% | -174.8% | – | – | |
| – | – | -100.0% | – | -77.4% | +188.7% | -72.6% | -61.2% | +21.1% | -100.0% | – | – | – | |
| – | -94.3% | +2,500.4% | -7.1% | – | -29.6% | -24.7% | +30.4% | +75.2% | +3.0% | -14.7% | -241.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -100.2% | – | +20.0% | -100.0% | – | – | -100.3% | – | -100.4% | – | |
| – | – | – | -193.3% | – | -193.7% | – | – | – | -106.8% | – | -192.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.